CARLOS
MACAYA MIGUEL
Profesor emérito
Hospital General Universitario de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (8)
2024
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
2019
-
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial
Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
2011
-
Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: Results from a Spanish multicentre registry
EuroIntervention, Vol. 6, Núm. 9, pp. 1080-1084